Data / Form D filings / KaloCyte, Inc.
KaloCyte, Inc.: Form D filing
KaloCyte, Inc., a biotechnology company in St. Louis, MO, filed a Form D with the SEC in 2018. The latest, on May 8, 2018, reports $800,000 sold of a $800,000 offering to 3 investors.
Find out what KaloCyte, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4320 FOREST PARK, SUITE 302, St. Louis, MO, 63108
- Phone
- (314) 809-9819
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Missouri
- Year incorporated
- 2016
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1738542
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 8, 2018 | New notice | $800,000 | $800,000 | $0 | 3 | Apr 27, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Dipanjan Pan | Director | |
| Daniel Getman | Director | |
| Allan Doctor | Executive Officer, Director | |
| Gregory Lanza | Director | |
| Philip Spinella | Director |
Every Form D from the week of May 7, 2018 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what KaloCyte, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.